The signal sequence of lymphocytic choriomeningitis virus contains an immunodominant cytotoxic T cell epitope that is restricted by both H-2Db and H-2Kb molecules

Virology

Volumn 234, Issue 1, 1997, Pages 62-73

  Hudrisier, Denis ^a   Oldstone, Michael B A ^b   Gairin, Jean Edouard ^a  

^a INSTITUT DE PHARMACOLOGIE ET DE BIOLOGIE STRUCTURALE   (France)

^b SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; VIRUS PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; CYTOTOXICITY; IMMUNE RESPONSE; IN VITRO STUDY; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALIA; CHORIOMENINGITIS VIRUS; LYMPHOCYTIC CHORIOMENINGITIS VIRUS;

EID: 0031582626     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1997.8627     Document Type: Article

References (64)

1. Aichele P., Kyburz D., Ohashi P., Odermatt B., Zinkernagel R. M., Henartner H., Pircher H. Peptide-induced T-cell tolerance to prevent autoimmune diabetes in a transgenic mouse model. Proc. Natl. Acad. Sci. USA. 91:1994;444-448.
2. Aichele P., Brduscha-Riem K., Zinkernagel R. M., Henartner H., Pircher H. T cell priming versus T cell tolerance induced by synthetic peptide. J. Exp. Med. 182:1995;261-266.
3. Ajitkumar P., Geier S. S., Kesari K. V., Borriello F., Nakagawa M., Bluestone J. A., Saper M. A., Wiley D. C., Nathenson S. G. Evidence that multiple residues on both the alpha-helices of the class I MHC molecule are simultaneously recognized by the T cell receptor. Cell. 54:1988;47-56.
4. Barber L. D., Parham P. The essence of epitopes. J. Exp. Med. 180:1994;1191-1194.
5. Bergmann C. C., Tong L., Cua R. V., Sensintaffar J. L., Stohlman S. A. Cytotoxic T cell repertoire selection - A single amino acid determines alternative class I restriction. J. Immunol. 152:1994;5603-5612.
6. Byrne J. A., Ahmed R., Oldstone M. B. A. Biology of cloned cytotoxic T lymphocytes specific for lymphocytic choriomeningitis virus. J. Immunol. 133:1984;433-439.
7. Chen Y., Sidney J., Southwood S., Cox A. L., Sakaguchi K., Henderson R. A., Appella E., Hunt D. F., Sette A., Engelhard V. H. Naturally processed peptides longer than nine amino acid residues bind to the class I MHC molecule HLA-A2.1 with high affinity and in different conformations. J. Immunol. 152:1994;2874-2881.
8. Colbert R. A., Rowlandjones S. L., Mcmichael A. J., Frelinger J. A. Differences in peptide presentation between B27 subtypes: The importance of the P1 side chain in maintaining high affinity peptide binding to B*2703. Immunity. 1:1994;121-130.
9. Cole G. A., Hogg T. L., Woodland D. L. The MHC class I-restricted T cell response to Sendai virus infection in C57BL/6 mice: a single immunodominant epitope elicits an extremely diverse repertoire of T cells. Int. Immunol. 6:1994;1767-1775.
10. Delguercio M. F., Sidney J., Hermanson G., Perez C., Grey H. M., Kubo R. T., Sette A. Binding of a peptide antigen to multiple HLA alleles allows definition of an A2-like supertype. J. Immunol. 154:1995;685-693.
11. b. Eur. J. Immunol. 22:1992;1603-1608.
12. Falk K., Rotzschke O., Rammensee H. G. Cellular peptide composition governed by major histocompatibility complex class I molecules. Nature. 348:1990;248-251.
13. Falk K., Rotzschke O., Stevanovic S., Jung G., Rammensee H. G. Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules. Nature. 351:1991;290-296.
14. Franco A., Ferrari C., Sette A., Chisari F. V. Viral mutations, TCR antagonism and escape from the immune response. Curr. Opin. Immunol. 7:1995;524-531.
15. Fruci D., Greco G., Vigneti E., Tanigaki N., Butler R. H., Tosi R. The peptide-binding specificity of HLA-B27 subtype (B*2705) analyzed by the use of polyalanine model peptides. Hum. Immunol. 41:1994;34-38.
16. +. J. Exp. Med. 180:1994;959-967.
17. b. J. Virol. 69:1995;2297-2305.
18. Garboczi D. N., Ghosh P., Utz U., Fan Q. R., Biddison W. E., Wiley D. C. Structure of the complex between human T-cell receptor, viral peptide and HLA-A2. Nature. 384:1996;134-141.
19. Garcia K. C., Degano M., Stanfield R. L., Brunmark A., Jackson M. R., Peterson P. A., Teyton L., Wilson I. A. An αβ T cell structure at 2.5 Å and its orientation in the TCR-MHC complex. Science. 274:1996;209-219.
20. b. Proc. Natl. Acad. Sci. USA. 79:1982;4737-4741.
21. b. J. Biol. Chem. 271:1996;17829-17836.
22. b. Mol. Immunol. 32:1995;895-907.
23. Jameson S., Bevan M. Dissection of major histocompatibility complex (MHC) and T cell receptor contact residues in a Kb-restricted ovalbumin peptide and an assessment of the predictive power of MHC-binding motifs. Eur. J. Immunol. 22:1992;2663-2667.
24. b. Proc. Natl. Acad. Sci. USA. 91:1994;4145-4149.
25. Kast W. M., Roux L., Curren J., Blom H. J. J., Voordouw A. C., Meloen R. H., Kolakofsky D., Melief C. J. M. Protection against lethal Sendai virus infection by in vivo priming of virus-specific cytotoxic T lymphocytes with a free synthetic peptide. Proc. Natl. Acad. Sci. USA. 88:1991;2283-2287.
26. Kikuchi A., Sakaguchi T., Miwa K., Takayima Y., Rammensee H. G., Kaneko Y., Takiguchi M. Binding of nonamer peptides to three HLA-B51 molecules which differ by a single amino acid substitution in the A-pocket. Immunogenetics. 43:1996;268-276.
27. Klavinskis L. S., Whitton J. L., Joly E., Oldstone M. B. A. Vaccination and protection from a lethal viral infection: Identification, incorporation and use of a cytotoxic T lymphocyte glycoprotein epitope. Virology. 178:1992;393-400.
28. Kozlowski S., Corr M., Shirai M., Boyd L. F., Pendleton C. D., Berzofsky J. A., Margulies D. H. Multiple Pathways Are Involved in the Extracellular Processing of MHC Class-I-Restricted Peptides. J. Immunol. 151:1993;4033-4044.
29. Kyburz P., Aichele P., Speiser D. E., Hengartner H., Zinkernagel R. M., Pircher H. T cell immunity after viral infection versus T cell tolerance induced by soluble viral peptides. Eur. J. Immunol. 23:1993;1956-1962.
30. Lewicki H., Tishon A., Borrow P., Evans C. F., Gairin J. E., Hahn K. M., Jewell D. A., Wilson I. A., Oldstone M. B. A. CTL escape viral variants .1. Generation and molecular characterization. Virology. 210:1995;29-40.
31. Lewicki H., von Herrath M. G., Evans C. F., Whitton J. L., Oldstone M. B. A. CTL escape viral variants .2. Biologic activity in vivo. Virology. 211:1995a;443-450.
32. Luescher I. F., Romero P., Kuznetsov D., Rimoldi D., Coulie P., Cerottini J.-C., Jongeneel C. V. HLA photoaffinity labeling reveals overlapping binding homologous melanoma-associated gene peptides by HLA-A1, HLA-A29 and HLA-B44. J. Biol. Chem. 271:1996;12463-12471.
33. Malarkannan S., Goth S., Buchholz D. R., Shastri N. The role of MHC class I molecules in the generation of endogenous peptide/MHC complexes. J. Immunol. 154:1995;585-598.
34. Matsumura M., Fremont D. H., Peterson P. A., Wilson I. A. Emerging principles for the recognition of peptide antigens by MHC class I molecules. Science. 257:1992;927-934.
35. Missale G., Redeker A., Person J., Fowler P., Guilhot H. S., Schlicht J., Ferrari C., Chisari F. V. HLA-A31 and HLA-w68-restricted cytotoxic T cell responses to a single hepatitis B virus nucleocapsid epitope during acute viral hepatitis. J. Exp. Med. 177:1993;751-762.
36. Moskophidis D., Zinkernagel R. M. Immunobiology of cytotoxic T-cell escape mutants of lymphocytic choriomeningitis virus. J. Virol. 69:1995;2187-2193.
37. b. J. Virol. 69:1995;6665-6677.
38. Ojcius D. M., Langlade-Demoyen P., Gachelin G., Kourilsky P. Role for MHC Class I molecules in selecting and protecting high affinity peptides in the presence of proteases. J. Immunol. 152:1994;2798-2810.
39. Oldstone M. B. A., Lewicki H., Borrow P., Hudrisier D., Gairin J. E. Discriminated selection among viral peptides with the appropriate anchor residues: implications for the size of the CTL repertoire and control of viral infection. J. Virol. 69:1995;7423-7429.
40. Oldstone M. B. A., Tishon A., Geckeler R., Lewicki H., Whitton J. L. A common antiviral cytotoxic T-lymphocyte epitope for diverse major histocompatibility complex haplotypes: Implication for vaccination. Proc. Natl. Acad. Sci. USA. 89:1992;2752-2755.
41. b. J. Exp. Med. 168:1988;559-570.
42. d. J. Immunol. 125:1980;2473-2477.
43. Pircher H., Moskophidis D., Rohrer U., Burki K., Hengartner H., Zinkernagel R. M. Viral escape by selection of cytotoxic T cell-resistant virus variantsin vivo. Nature. 346:1990;629-633.
44. Quaratino S., Thorpe C. J., Travers P. J., Londei M. Similar antigenic surfaces, rather than sequence homology, dictate T cell epitope molecular mimicry. Proc. Natl. Acad. Sci. USA. 92:1995;10398-10402.
45. Rammensee H. G., Friede T., Stevanovic S. MHC Ligands and peptide motifs: First listing. Immunogenetics. 41:1995;178-228.
46. Ruppert J., Sidney J., Celis E., Kubo R. T., Grey H. M., Sette A. Prominent role of secondary anchor residues in peptide binding to HLA-A2.1 molecules. Cell. 74:1993;929-937.
47. Saito Y., Peterson P. A., Matsumura M. Quantitation of peptide anchor residue contributions to class-I major histocompatibility complex molecule binding. J. Biol. Chem. 268:1993;21309-21317.
48. Schulz M., Aichele P., Wollenweider M., Bobe F. W., Cardinaux F., Hengartner H., Zinkernagel R. M. Major Histocompatibility Complex-dependent T cell epitopes of lymphocytic choriomeningitis virus nucleoprotein and their protective capacity against viral disease. Eur. J. Immunol. 19:1989;1657-1667.
49. Schumacher T. N. M., DeBruijn M. L. H., Bernie L. N., Kast W. M., Melief C. J. M., Neefjes J. J., Ploegh H. L. Peptide selection by MHC class I molecules. Nature. 350:1991;703-706.
50. Sheil J. M., Schell T. D., Shepherd S. E., Klimo G. F., Kioschos J. M., Paterson Y. Presentation of a horse cytochrome c peptide by multiple H-2b class I major histocompatibility complex (MHC) molecules to C57BL/6 and bml-derived cytotoxic T lymphocytes: Presence of a single MHC anchor residue may confer efficient peptide-specific CTL recognition. Eur. J. Immunol. 24:1994;2141-2149.
51. b. Proc. Natl. Acad. Sci. USA. 89:1992;3135-3139.
52. Shirai M., Pendleton C. D., Berzofsky J. A. Broad recognition of cytotoxic T cell epitopes from the HIV-1 envelope protein with multiple class I histocompatibility molecules. J. Immunol. 148:1992;1657-1667.
53. Sidney J., Delguercio M. F., Southwood S., Engelhard V. H., Appella E., Rammensee H. G., Falk K., Rotzschke O., Takiguchi M., Kubo R. T., Grey H. M., Sette A. Several HLA alleles share overlapping peptide specificities. J. Immunol. 154:1995;247-259.
54. b. Immunity. 3:1995;573-582.
55. Tanigaki N., Fruci D., Vigneti E., Starace G., Rovero P., Londei M., Butler R. H., Tosi R. The peptide binding specificity of HLA-B27 subtypes. Immunogenetics. 40:1994;192-198.
56. Tishon A., Lewicki H., Rall G., von Herrath M., Oldstone M. B. A. An essential role for type 1 interferon-g in terminating persistent viral infection. Virology. 212:1995;244-250.
57. Tussey L. G., Rowland-Jones S., Zheng T. S., Androlewicz M. J., Creswell P., Frelinger J. A., McMichael A. J. Different MHC class I alleles compete for presentation of overlapping viral epitopes. Immunity. 3:1995;65-77.
58. van der Most R., Sette A., Oseroff C., Alexander J., Murali-Krishna K., Lau L. L., Southwood S., Sidney J., Chesnut R. W., Matloubian M., Ahmed R. Analysis of cytotoxic T cell responses to dominant and subdominant epitopes during acute and chronic lymphocytic choriomeningitis virus infection. J. Immunol. 157:1996;5543-5554.
59. von Herrath M. G., Efrat S., Oldstone M. B. A., Horwitz M. S. Expression of adenoviral E3 transgenes in β-cells prevents autoimmune diabetes. J. Clin. Invest. 1997.
60. von Herrath M. G., Gairin J. E., Coon B., Oldstone M. B. A. A specific MHC class I restricted "blocking peptide" prevents activation of virus-induced CTL and the development of virus induced autoimmune diabetes. Immunity. 1997a.
61. Whitton J. L., Southern P. J., Oldstone M. B. A. Analysis of the cytotoxic T lymphocyte responses to glycoprotein and nucleoprotein components of lymphocytic choriomeningitis virus. Virology. 162:1988;321-327.
62. Wilson C. C., Kalams S. A., Wilkes B. M., Ruhl D. J., Gao F., Hahn B. H., Hanson I. C., Luzuriaga K., Wolinsky S., Koup R., Buchbinder S. P., Johnson R. P., Walker B. D. Overlapping epitopes in human immunodeficiency virus type 1 gp120 presented by HLA A, B, C molecules: effects of viral variation on cytotoxic T-lymphocyte recognition. J. Virol. 71:1996;1256-1264.
63. b. Cell. 76:1994;39-50.
64. b. Proc. Natl. Acad. Sci. USA. 89:1992;8403-8407.